Ageless Peptides

Research comparison

IGF-1 LR3 vs Tesamorelin

IGF-1 LR3 and Tesamorelin compared: structure, identity data and regulatory status, with cited sources. Research Use Only.

By Ageless Research TeamReviewed November 15, 2026

IGF-1 LR3 and tesamorelin differ in size and class. IGF-1 LR3 is an engineered 83-amino-acid IGF-1 protein analogue; tesamorelin is a 44-amino-acid GHRH peptide analogue. WADA lists them in different sections, S2.3 and S2.2.4.

PropertyIGF-1 LR3Tesamorelin
ClassEngineered 83-amino-acid IGF-1 analogue (Arg at position 3, 13-residue N-terminal extension) [1]Synthetic 44-amino-acid GHRH (GRF) analogue with an N-terminal trans-3-hexenoyl group [2]
Molecular formulaNot given in the cited recordsC221H366N72O67S [2]
Molecular weight (g/mol)Not given in the cited records5136 [2]
CAS number946870-92-4 [3]218949-48-5 [2]
PubChem CIDNone16137828
SequenceNot given in the cited recordstrans-3-hexenoyl-hGRF(1-44)NH2 [2]
Regulatory statusResearch material; not an FDA-approved drug productResearch material; not an FDA-approved drug product
WADA 2026IGF-1 and its analogues named under S2.3, prohibited at all times [4]Named under S2.2.4 (GHRH analogues), prohibited at all times [4]
Supplied by Ageless PeptidesYesYes

IGF-1 LR3

IGF-1 LR3: engineered 83-amino-acid IGF-1 analogue (Arg at position 3, 13-residue N-terminal extension). [1] FDA: research material, not an FDA-approved drug product; not for human or veterinary use. WADA 2026: iGF-1 and its analogues named under S2.3, prohibited at all times. [4]

Full reference: IGF-1 LR3 research reference

Tesamorelin

Tesamorelin: synthetic 44-amino-acid GHRH (GRF) analogue with an N-terminal trans-3-hexenoyl group. [2] FDA: research material, not an FDA-approved drug product; not for human or veterinary use. WADA 2026: named under S2.2.4 (GHRH analogues), prohibited at all times. [4]

Full reference: Tesamorelin research reference

Storage and handling

Both are supplied as lyophilized solids in sealed vials. Store sealed vials at -20°C, protected from light and moisture, and allow a cold vial to reach room temperature before opening. Product-specific conditions are listed on each product page and Safety Data Sheet.

Lot documentation

Each lot of each product has its own Certificate of Analysis. Each vial label carries a serial number linked to its lot: scan the code on the label and enter the serial number to see the COA for that vial's lot. Compare products only against the COA for the exact lot used.

Research use only

Ageless Peptides supplies these compounds as lyophilized material for laboratory research only. They are not drugs, foods, cosmetics or dietary supplements, are not for human or veterinary use, and nothing on this page is medical advice or a statement of safety or effectiveness for any human or veterinary use.

Frequently asked questions

What is the difference between IGF-1 LR3 and Tesamorelin?
IGF-1 LR3 and tesamorelin differ in size and class. IGF-1 LR3 is an engineered 83-amino-acid IGF-1 protein analogue; tesamorelin is a 44-amino-acid GHRH peptide analogue. WADA lists them in different sections, S2.3 and S2.2.4.
How do the molecular formulas of IGF-1 LR3 and Tesamorelin compare?
IGF-1 LR3: not given in the cited records, CAS 946870-92-4. Tesamorelin: C221H366N72O67S, about 5136 g/mol, CAS 218949-48-5.
Are IGF-1 LR3 and Tesamorelin FDA-approved?
The research materials compared here are not FDA-approved drug products and are not for human or veterinary use.
How should sealed IGF-1 LR3 and Tesamorelin vials be stored?
Store sealed lyophilized vials at -20°C, protected from light and moisture. Product-specific conditions are on each product page and Safety Data Sheet.
Where do I find the COA for each lot?
Scan the code on the vial label and enter its serial number to see the Certificate of Analysis for that vial's lot.

Products

References

  1. Insulin-Like Growth Factor-1 (IGF-1) and Its Monitoring in Medical Diagnostic and in Sport
  2. PubChem compound CID 16137828
  3. PubChem substance SID 476298411 (IGF-1 LR3)
  4. World Anti-Doping Code International Standard Prohibited List 2026. 2026

For Research Use Only. Not for human or veterinary use.

Product Index